Overview

Ketoconazole and Dexamethasone in Prostate Cancer

Status:
Completed

Trial end date:
2014-10-09

Target enrollment:

Participant gender:

Summary

This is an open label, phase II, single center trial of ketoconazole/dexamethasone to determine if the administration of ketoconazole/dexamethasone, after disease progression with ketoconazole/hydrocortisone slows or reverses disease progression in men with progressive prostate cancer.

Phase:

Phase 2

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

BB 1101
Cortisol succinate
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Ketoconazole